Antiplatelet and antithrombotic activities of CP201, a newly synthesized 1,4-naphthoquinone derivative

Vascular Pharmacology

Volumn 41, Issue 1, 2004, Pages 35-41

  Jin, Yong Ri ^a   Hwang, Kyung Ae ^a   Cho, Mi Ra ^a   Kim, Soo Yeon ^a   Kim, Jin Ho ^a   Ryu, Chung Kyu ^b   Son, Dong Ju ^c   Park, Young Hyun ^c   Yun, Yeo Pyo ^a  

^a Chungbuk National University   (South Korea)

^b Ewha Womans University   (South Korea)

^c Soonchunhyang University   (South Korea)

Author keywords

Antiplatelet; Antithrombosis; Calcium mobilization; Naphthoquinone

Indexed keywords

1,4 NAPHTHOQUINONE DERIVATIVE; 2 (3,5 DI TERT BUTYL 4 HYDROXYL) 3 CHLORO 1,4 NAPHTHOQUINONE; ADENOSINE TRIPHOSPHATASE (CALCIUM); ADRENALIN; ANTITHROMBOCYTIC AGENT; CALCIMYCIN; COLLAGEN; CP 201; THAPSIGARGIN; THROMBIN; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTICLE; BLOOD CLOTTING; CALCIUM SIGNALING; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSOL; CYTOTOXICITY; DOSE RESPONSE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IC 50; LUNG EMBOLISM; MALE; MOUSE; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; THROMBIN TIME; THROMBOCYTE AGGREGATION;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBRINOLYTIC AGENTS; HUMANS; MALE; MICE; MICE, INBRED ICR; NAPHTHOQUINONES; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PULMONARY EMBOLISM;

EID: 2342649953     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2004.04.001     Document Type: Article

References (45)

1. Albers G.W. Antithrombotic agents in cerebral ischemia. Am. J. Cardiol. 75:1995;34B-38B
2. Antithrombotic Trialists' Collaboration Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 324:2002;71-86
3. Berridge M.J. Inositol trisphosphate and calcium signalling. Nature. 361:1993;315-325
4. Born G.V., Cross M.J. The aggregation of blood platelets. J. Physiol. 168:1963;178-195
5. 2 during arachidonate infusion in rabbits. Thromb. Res. 12:1978;549-553
6. Chang T.S., Lee K.S., Lee G.Y., Jeon S.D., So D.S., Khil L.Y., Chung M.K., Moon C.K. NQ-Y15 inhibits the calcium mobilization by elevation of cyclic AMP in rat platelets. Biol. Pharm. Bull. 24:2001;480-483
7. Chen X., Yang L., Oppenheim J.J., Howard M.Z. Cellular pharmacology studies of shikonin derivatives. PTR, Phytother. Res. 16:2002;199-209
8. Colman R., Cook J., Niewiarowski S. Hemostasis and thrombosis. vol. 1:1994;509-525 J.B. Lippincott, Philadelphia
9. Cowan D.H. Platelet adherence to collagen: role of prostaglandin- thromboxane synthesis. Br. J. Haematol. 49:1981;425-434
10. Cowan D.H., Robertson A.L., Shook P., Giroski P. Platelet adherence to collagen: role of plasma, ADP, and divalent cations. Br. J. Haematol. 47:1981;257-267
11. DiMinno G., Silver M.J. Mouse antithrombotic assay: a simple method for the evaluation of antithrombotic agents in vivo. Potentiation of antithrombotic activity by ethyl alcohol. J. Pharmacol. Exp. Ther. 225:1983;57-60
12. 2+ ionophores. Br. J. Haematol. 112:2001;603-608
13. George J.N. Platelets. Lancet. 355:2000;1531-1539
14. Godfraind T. Calcium antagonists and vasodilatation. Pharmacol. Ther. 64:1994;37-75
15. Heemskerk J.W., Vis P., Feijge M.A., Hoyland J., Mason W.T., Sage S.O. Roles of phospholipase C and Ca(2+)-ATPase in calcium responses of single, fibrinogen-bound platelets. J. Biol. Chem. 268:1993;356-363
16. 2+-channels. Eur. J. Pharmacol. 341:1998;343-347
17. Kang W.S., Chung K.H., Chung J.H., Lee J.Y., Park J.B., Zhang Y.H., Yoo H.S., Yun Y.P. Antiplatelet activity of green tea catechins is mediated by inhibition of cytoplasmic calcium increase. J. Cardiovasc. Pharmacol. 38:2001;875-884
18. Kaul U., Gupta R.K., Haridas K.K., Ramesh S.S., Sethi K.K., Singh B., Agarwal R., Yadave R.D., Ghose T., Sapra R.R., Bajaj R., Shahi M., Bhagwat A., Kumar P., Mathews O.P., Soni P.K. Platelet glycoprotein IIb/IIIa inhibition using eptifibatide with primary coronary stenting for acute myocardial infarction: a 30-day follow-up study. Catheter. Cardiovasc. Interv. 57:2002;497-503
19. Kim H.S., Zhang Y.H., Yun Y.P. Effects of tetrandrine and fangchinoline on experimental thrombosis in mice and human platelet aggregation. Planta Med. 65:1999;135-138
20. Ko F.N., Lee Y.S., Kuo S.C., Chang Y.S., Teng C.M. Inhibition on platelet activation by shikonin derivatives isolated from Arnebia euchroma. Biochim. Biophys. Acta. 1268:1995;329-334
21. Ko T.C., Hour M.J., Lien J.C., Teng C.M., Lee K.H., Kuo S.C., Huang L.J. Synthesis of 4-alkoxy-2-phenylquinoline derivatives as potent antiplatelet agents. Bioorg. Med. Chem. Lett. 11:2001;279-282
22. Kucera G.L., Rittenhouse S.E. Human platelets form 3-phosphorylated phosphoinositides in response to alpha-thrombin, U46619, or GTP gamma S. J. Biol. Chem. 265:1990;5345-5348
23. Lapetina E.G. The signal transduction induced by thrombin in human platelets. FEBS Lett. 268:1990;400-404
24. 2 in Rat-2 fibroblasts. J. Biol. Chem. 273:1998;12710-12715
25. Liao C.H., Ko F.N., Kuo S.C., Teng C.M. Effect of PP1D-1, a synthetic antiplatelet compound, on rabbit platelets. Jpn. J. Pharmacol. 76:1998;141-148
26. Lien J.C., Huang L.J., Teng C.M., Wang J.P., Kuo S.C. Synthesis of 2-alkoxy 1, 4-naphthoquinone derivatives as antiplatelet, antiinflammatory, and antiallergic agents. Chem. Pharm. Bull. (Tokyo). 50:2002;672-674
27. Mazur W., Kaluza G.L., Sapp S., Balog C., Topol E.J., Mark D.B., Ellis S.G., Kereiakes D.J., Lincoff A.M., Kleiman N.S. Glycoprotein IIb-IIIa inhibition with abciximab and postprocedural risk assessment: lessons from the evaluation of platelet IIb/IIIa inhibitor for stenting trial and implication for ad hoc use of glycoprotein IIb-IIIa antagonists. Am. Heart J. 143:2002;594-601
28. Montalescot G., Barragan P., Wittenberg O., Ecollan P., Elhadad S., Villain P., Boulenc J.M., Morice M.C., Maillard L., Pansieri M., Choussat R., Pinton P. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N. Engl. J. Med. 344:2001;1895-1903
29. Niiya K., Hodson E., Bader R., Byers-Ward V., Koziol J.A., Plow E.F., Ruggeri Z.M. Increased surface expression of the membrane glycoprotein IIb/IIIa complex induced by platelet activation. Relationship to the binding of fibrinogen and platelet aggregation. Blood. 70:1987;475-483
30. Nishizawa E., Wynalda D.J., Suydam D.E., Sawa T.R., Schultz J.R. Collagen-induced pulmonary thromboembolism in mice. Thromb. Res. 1972;233-242
31. Nolan R.D., Lapetina E.G. Thrombin stimulates the production of a novel polyphosphoinositide in human platelets. J. Biol. Chem. 265:1990;2441-2445
32. Oates J.A. Antihypertensive agents and the drug therapy of hypertension. The Pharmacological Basis of Therapeutics. 9th ed. 1996;80-808 McGraw-Hill, New York
33. Odawara A., Kikkawa K., Katoh M., Toryu H., Shimazaki T., Sasaki Y. Inhibitory effects of TA-993, a new 1, 5-benzothiazepine derivative, on platelet aggregation. Circ. Res. 78:1996;643-649
34. Rink T.J., Sage S.O. Calcium signaling in human platelets. Annu. Rev. Physiol. 52:1990;431-449
35. Rodriguez S., Wolfender J.L., Hakizamungu E., Hostettmann K. An antifungal naphthoquinone, xanthones and secoiridoids from Swertia calycina. Planta Med. 61:1995;362-364
36. Ryu C.K. Synthesis of anticoagulant 2-choro-3-(n-aryIamino)-1, 4-naphthoquinones. Yakhak Hoeji. 32:1988;245-250
37. Sage S.O. The Wellcome Prize lecture. Calcium entry mechanisms in human platelets. Exp. Physiol. 82:1997;807-823
38. Shen A.Y., Huang M.H., Teng C.M., Wang J.S. Inhibition of 2-P-mercaptophenyl-1, 4-naphthoquinone on human platelet function. Life Sci. 65:1999;45-53
39. Siess W. Molecular mechanisms of platelet activation. Physiol. Rev. 69:1989;58-178
40. Silver M.J., Hoch W., Kocsis J.J., Ingerman C.M., Smith J.B. Arachidonic acid causes sudden death in rabbits. Science. 183:1974;1085-1087
41. Smith J.B., Selak M.A., Dangelmaier C., Daniel J.L. Cytosolic calcium as a second messenger for collagen-induced platelet responses. Biochem. J. 288:1992;925-929
42. Sun B., Kambayashi J. Discrete intracellular Ca(2+) pools coupled to two distinct Ca(2+) influx pathways in human platelets. J. Biomed. Sci. 7:2000;35-41
43. Vizcaino-Salazar G. Platelet physiology. Advances in platelet reactivity. Review. Invest. Clin. 35:1994;41-62
44. Yuk D.Y., Ryu C.K., Hong J.T., Chung K.H., Kang W.S., Kim Y., Yoo H.S., Lee M.K., Lee C.K., Yun Y.P. Antithrombotic and antiplatelet activities of 2-chloro-3-[4-(ethylcarboxy)-phenyl]-amino-1, 4-naphthoquinone (NQ12), a newly synthesized 1, 4-naphthoquinone derivative. Biochem. Pharmacol. 60:2000;1001-1008
45. 2+mobilization. Biol. Pharm. Bull. 24:2001;618-622